Results 51 to 60 of about 32,366 (210)

C-type lectin 4 regulates broad-spectrum melanization-based refractoriness to malaria parasites. The underlying data for all graphs.

, 2022
Underlying data for all graphs in "C-type lectin 4 regulates broad-spectrum melanization-based refractoriness to malaria ...
George Dimopoulos (17514), Godfree Mlambo (113310), Mlambo, Godfree, Simões, Maria Luisa, Maria L. Simões (4923364), Dong, Yuemei, Yuemei Dong (17509), Dimopoulos, George   +7 more
core   +1 more source

Platelet Refractoriness and HLA Matched Platelets Slidedeck

Slide deck summarizing causes of platelet refractoriness and transfusion strategies for immune-refractoriness including HLA-matched versus crossmatch-compatible platelets.
David Allison (9094295)
core   +1 more source

Exploring Refractoriness as an Adjunctive Electrical Biomarker for Staging of Atrial Fibrillation [PDF]

, 2020
Patients diagnosed with the same subtype of atrial fibrillation according to our current classification system may differ in symptom severity, severity of the arrhythmogenic substrate, and response to antiarrhythmic therapy. Hence, there is a need for an
Groot, N.M.S. (Natasja) de, de Groot, Natasja, van Staveren, L.N. (Lianne N.), van Staveren, L.N., de Groot, N.M.S., van Staveren, Lianne, Lianne N. van Staveren, Natasja M. S. de Groot   +7 more
core   +1 more source

Models to investigate some issues regarding the feasibility of driving refractoriness genes into mosquito vector populations [PDF]

, 2006
A genetic driving system extremely closely genetically linked to a refractoriness gene is needed if such genes are to be of any use in the control of vector-borne disease.
Curtis, CF
core   +2 more sources

Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Клиническая онкогематология, 2019
Aim. To assess the efficacy of FLAG/FLAG-Ida regimen and to identify factors that influence remission, duration of disease-free survival (DFS) and overall survival (OS) of patients with relapsed/refractory acute myeloid leukemia (AML).
Irina Garmaevna Budaeva, E. G. Ovsyannikova, E. N. Goryunova, O. V. Kulemina, D. V. Zaitsev, D. V. Motorin, R. Sh. Badaev, D. B. Zammoeva, V. V. Ivanov, K. V. Bogdanov, O. S. Pisotskaya, Yu. V. Mirolyubova, T. S. Nikulina, Yu. A. Alekseeva, A. Yu. Zaritskey, L. L. Girshova   +15 more
doaj   +1 more source

MOESM1 of Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions

, 2018
Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness ...
Britta Eiz-Vesper (109926), Thomas Moritz (54137), Susanne Aufderbeck (5816534), Christiane Gras (5816531), Carlos Guzman (3710965), Nico Lachmann (3507401), Ulrich Martin (62121), Ann-Kathrin Bรถrger (5816522), Dorothee Eicke (5816525), Kai Schulze (618887), Axel Schambach (214256), Constanรงa Figueiredo (5816540), Lena Engels (5816537), Christina Wolf (5816528), Rainer Blasczyk (109922)   +14 more
core   +1 more source

Case Study: HLA incompatible platelet infusion to allow emergency salvage HCT in a patient with primary graft failure due to donor specific HLA antibody

Frontiers in Immunology
A patient with myelodysplasia received a haploidentical hematopoietic stem cell transplant (HCT). Pre-transplant HLA antibody screening showed no detectable donor-specific antibodies (DSAs). Post-transplant, the patient developed an anti-HLA-A2 antibody,
Louise Goddard, Jonathan Moses, Gerard Joseph Chu, Robert P. Carroll   +3 more
doaj   +1 more source

The Use of Ibrutinib in Refractory Chronic Lymphocytic Leukemia and in High-Risk Patients

Клиническая онкогематология, 2019
Despite advances in chemo-immunotherapy of chronic lymphocytic leukemia, a choice of therapy is a frequent challenge in patients with a refractory form of the disease, autoimmune hemolytic complications, and also in high-risk patients with cytogenetic ...
Nadezhda Viktorovna Kurkina, E. A. Repina, N. N. Mashnina   +2 more
doaj   +1 more source

Treatment of Relapsed and Refractory Hodgkin’s Lymphoma in Children

Клиническая онкогематология, 2016
Background & Aims. Most children with Hodgkin’s lymphoma (HL) can be cured irrespective of the disease stage using modern risk adapted protocols. But 3–5 % of children develop relapse of the disease or refractoriness to the treatment performed.
N. S. Kulichkina, E. S. Belyaeva, G. L. Mentkevich, V. K. Boyarshinov, A. S. Levashov, I. V. Glekov, Aleksandr Valentinovich Popa   +6 more
doaj   +1 more source

The role of luminal Ca regulation in Ca signaling refractoriness and cardiac arrhythmogenesis

, 2017
Györke et al. discuss the role of sarcoplasmic reticulum Ca2+ in cardiac refractoriness and pathological implications.
Igor V. Kubasov, Przemysław B. Radwański, Cynthia A. Carnes, Bin Liu, Andriy E. Belevych, Sándor Györke   +5 more
core   +1 more source